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Small Cell Carcinoma of the Lung in the Intensive Care Unit
Paul Harkaway, MD,* Cynthia Glines, MD,^ Michael Eichenhorn, MD,+ Paul Kvale,
MD,+ Robert Chapman, MD,* and John Popovich, Jr, MD*

The outcome of29 patients with a diagnosis of small cell carcinoma ofthe lung admitted to the medical
intensive care unit (MICU) from 1980 through 1984 was reviewed retrospectively. Respiratoryfailure
was the most common admitting diagnosis (23 patients [80%]). followed by cardiopulmonary arrest
(three patients [ 10% ]). and hypotension (three patients [10%] ). Onlyfivepatients survived to leave the
MICU. and only two of these patients lived longer than two months after MICU discharge. Of the
features examined, the absence of sepsis was the only statistically significant predictor of MICU
survival. Treatment ofthe malignancy did not appear to alter the outcome even if endobronchial tumor
was thought to be a contributor to respiratory failure.
The outlook of patients with small cell carcinoma of the lung admitted to the MICU is grim,
and limitation of care should be considered in many ofthese patients. (Henry Ford Hosp Med J
1986;34:285-7)

S

mall cell carcinoma of the lung (SCLC) carries an overall
poor prognosis for survival even though this tumor is frequently responsive to radiotherapy and chemotherapy. However,
significant improvements in survival and control of local disease
have been noted after treatment with these modalities. Intensive
care unit patients with SCLC are frequently treated aggressively
when a critical illness arises in the hope that definitive treatment
of the cancer will assist in reversing the critical illness and/or
offer the possibility of prolonged survival once the acute illness
is overcome. To evaluate whether this optimistic outlook is justified, the outcome of patients with SCLC admitted to a medical
intensive care unit was reviewed.

Materials and Methods
The medical records of all (29) patients with SCLC admitted
to the medical intensive care unit (MICU) of a large teaching
hospital from 1980 through 1984 were reviewed retrospectively.
Besides basic demographic data, details such as extent and duration of disease, MICU admitting diagnosis, duration of survival,
treatment, organ system impairment, and presence of sepsis
were collected. In addition, duration of MICU stay and the total
cost of hospitalization were reviewed. All patients died before
this study was undertaken.
Organ system impairment was classified as described in a recent study on survival of patients with respiratory failure (1). Impairment of the hematologic sy.stem was defined as leukopenia,
thrombocytopenia, hematologic malignancy, or coagulopathy.
Central nervous system impairment included encephalopathy or
coma, cerebral infarct, meningitis, seizures, or malignancy. Involvement of the gastrointestinal system included gastrointestinal hemorrhage, ascites, hepatic failure or impairment.
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bowel obstmction, or pancreatitis. Cardiovascular compromise
included heart failure, clinically significant arrhythmia, myocardial infarction, or pericardial disease. Renal impairment included acute or chronic renal failure. Pulmonary involvement
was considered present if the patient had respiratory failure,
pneumonia, embolic disease, or chronic restrictive or obstmctive lung disease. Respiratory/ventilatory failure was defined as
the need for mechanical ventilation.
Sepsis was defined as the presence of any three of the following; temperature > 39°C, increase in pulse by 20 beats/minute
without other cause, systolic blood pressure ^ 80 without other
reason, altered mental status without other cause, elevated WBC
count S5 3000 above baseline or depression below 1000 total
neutrophils, positive blood cultures for a pathogen, unexplained
metabolic acidosis, or probable source for a systemic infection
(ie, pneumonia).
The characteristics of MICU survivors and nonsurvivors were
compared. The data were analyzed using Student's t test.
Fisher's exact test, or the nonparametric Mann-Whitney test
where appropriate. The multivariate technique used was a stepwise logistic regression.
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Table 1
Characteristics of MICU Survivors
Time from
Initial Diagnosis to MICU
Admission

MICU
Stay

Primary MICU
Admitting Diagnosis

1

45 days

6 days

2
3
4

36 days
290 days
211 days

6 days
2 days
3 days

5

0 days

3 days

Postoperative respiratory
failure
Respiratory failure
Respiratory failure
Respiratory failure
secondary to reexpansion
pulmonary edema
Hypotension

Patient

No. of Organ
Systems
Impaired

Extent of
Disease*

Survival Post
MICU
Discharge

2
2
3

F:
E
L

48 days
58 days
8 days

1
4

H
E

189 days
120 days

' E = extensive, L = limited. Limited disease means confined to one hemithorax.

Results
From 1980 through 1984 29 patients (16 men and 13 women)
with the diagnosis of SCLC were admitted to the MICU, accounting for 1% of patient admissions. The most common cause
for MICU admission was respiratory failure (23 patients [80%]),
followed by cardiopulmonary anest (three patients [10%]), and
hypotension (three patients [10%]). Overall MICU survival rate
for patients with SCLC was 17% (5 of 29 patients) compared to a
73% survival rate for all medical admissions. Only four (17%) of
the 23 patients presenting with respiratory failure survived to
leave the MICU. No patient with cardiopulmonary anest survived, and one patient with hypotension survived.
Of thefivepatients who survived to leave the MICU, one died
within eight days, and two others died before two months had
passed (at 48 days and 58 days, respectively) (Table 1). Two patients survived longer ( > two months). One patient was admitted to the MICU after developing reexpansion pulmonary edema
after thoracentesis and required a short period of mechanical
ventilation (three days); he survived for six months after MICU
discharge. The other patient was admitted with pneumonia and
hypotension secondary to hypovolemia and never required mechanical ventilation; he survived for four months after MICU
discharge.

Table 2
Mean Comparison of Features of MICU Nonsurvivors and
Survivors
Variables
Age
Time from initial
diagnosis to
MICU
admission
(days)
MICU stay (days)
No. of organ
systems
impaired
Total hospital cost

Nonsurvivors
63.1

112.5
15.5

Survivors
60.20

116.40
4.0

Significance*

> 0.64

NS

> 0.96
> 0.79

Table 3
Extent of Disease

NS
NS

Survival
2.7
$36,210

2.4
$28,500

*NS = not significant.
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p Value

The characteristics of MICU survivors and nonsurvivors are
outlined and compared in Table 2. Ofthe features compared,
none showed a statistically significant difference between the
two groups. There appeared to be an impressive difference in
length of MICU stay between the two groups, but it did not
achieve statistical significance. The number of organ systems
impaired did not differ between the two groups.
Extent of disease was compared between survivors and nonsurvivors, and no difference was noted (Table 3). However, data
on the extent of the disease were incomplete because many
patients had been recently diagnosed and therefore were not
completely staged when the catastrophic illness stmck. Using a
multivariate analysis, the absence of sepsis was the only significant covariant of survival (p < 0.03). None of the ten patients
with a diagnosis of sepsis survived to leave the MICU. Neutropenia was present infiveof the septic patients, and none survived despite recovery of the neutrophil counts in two patients.
All five MICU survivors received chemotherapy and/or radiation therapy either before or after MICU admission. Only two
patients showed a clear-cut response to therapy. One patient was
treated elsewhere after hospital discharge, and response data
were unavailable. Two patients were treated extensively prior to
MICU admission with no objective evidence of response. The
one patient in this series who survived six months after hospital
discharge showed no evidence of response to therapy.
Of the 24 patients who died in the MICU, eight patients did
not receive treatment for SCLC. In five of these patients the diagnosis was made after MICU admission and shortly before or
after death. In the other three patients the diagnosis was made
only a few days before MICU admission (five, eight, and 13
days, respectively), and therapy had not yet been initiated. All
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> 0.60
> 0.98

NS
NS

Disease*

No

Extensive
Limited

8
6

p Value

Yes
4 )
1 \

> 0.65
(not significant)

*Liniited nieans confined to one hemithorax. Al! else is extensive.
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three ofthese patients died within one day of MICU admission.
All other patients (16) received chemotherapy. Several patients
received radiation therapy as well. Nine ofthe 16 patients
showed some evidence of response to therapy, and four ofthese
patients had evidence of relapse prior to MICU admission.
Seven patients either had no response to therapy or their response could not be determined. Seven patients who were
treated with chemotherapy had received only one course prior to
their death.
Of the 23 patients with respiratory failure, eight patients
(35%) had tumor obstmction of major airways contributing to
tiie respiratory failure. None of these patients survived to leave
the MICU. Three patients received both radiation therapy and
chemotherapy, only one of whom demonstrated any response
prior to death. Ofthe two patients treated with laser photoresection in combination with chemotherapy and radiation therapy,
one showed significant improvement in aeration of the previously obstmcted lung. However, both patients died. One patient received chemotherapy alone, but died after one course
with no evidence of response. Two patients were not treated; one
refused therapy, and one was brain dead on arrival to the MICU.
The cause of death was unknown in all MICU survivors, two
of whom were in nursing homes at the time of their deaths. In the
MICU fatalities the most common cause of death was a terminal
cardiac event (12 of 24 patients [50%]). Refractory hypotension
was the cause of death in six patients, and brain death was the
cause in two patients. Two patients had artificial life support
withdrawn when they, along with the family and physician, felt
such action was appropriate. Two patients died of refractory respiratory failure.

Discussion
In thisfive-yearretrospective review the outcome of 29 patients with small cell carcinoma of the lung admitted to the
MICU was discouraging. The majority of patients (23) presented with respiratory failure as their primary MICU diagnosis, yet only four of these patients survived to leave the MICU
and only one of these four survived six months after discharge.
As mentioned, this patient was unusual in that he had an acute
reversible etiology for respiratory failure (reexpansion pulmonary edema). The results compare poorly with the overall outcome of patients requiring mechanical ventilation reported in
other series (intensive care unit survival ranging from 30% to
75%) (2-7). However, the results are not too dissimilar from
those reported for respiratory failure in cancer patients (1,8,9).
Of note, none of the patients who had tumor obstmction of major airways contributing to respiratory failure survived to leave
the MICU regardless of treatment.
None of the three patients who presented after cardiopulmonary anest survived. A recent study demonstrated a 14% survival
rate for cardiopulmonary arrest patients (10); however, the
number of patients in the present series is too small for mean-
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ingful comparison. In our study, patients with evidence of sepsis
did not survive regardless of whether they had neutropenia and
even if the neutropenia subsequently resolved
Clearly, it is difficult to draw firni conclusions from this study
since the total number of patients is small and there is marked
disparity in the size of the two groups compared (MICU survivors versus nonsurvivors). However, the results of this study
suggest some important conclusions. Based on the experience in
this hospital, it appears that the outcome of patients with SCLC
admitted to the MICU is quite poor. Patients who survived to
leave the MICU were few in number and their subsequent survival was short. Longer survivors ( ^ four months) had atypical
self-limited problems, prompting MICU admission. Our study
shows no evidence that treatment of patients with systemic
chemotherapy, radiotherapy, or laser photoresection improved
the outcome even if the tumor physically contributed to respiratory failure. All patients who suffered from sepsis or cardiopulmonary arrest died, and one would question if aggressive
therapy in these patients is justified.
Protracted MICU care with little hope for extended meaningful survival can only contribute to patient suffering. More
data are needed to draw firm conclusions, but based on this
study it appears that most patients with SCLC gain little from
MICU care. Limitations of care should be strongly considered
in these patients unless definitively reversible causes of critical
Uiness can be demonstrated.
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